Recent Evolution of Monographs for Dietary Supplements in USP

Similar documents
Pharmacopeial Perspectives on Vitamin Analysis

Reference Standards in the Analysis of Botanicals

USP Perspective on Atypical Actives November 29, 2017

U.S. Requirements for Dietary Supplement Ingredients and USP <2232> Elemental Impurities Is Your Company Ready for Implementation?

USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements

USP Guideline for Submitting Requests for Revision to USP NF SUBMISSION GUIDELINE FOR NON-BOTANICAL DIETARY SUPPLEMENTS TABLE OF CONTENTS

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

USP botanical quality standards: contributions in quality control & safe use of botanicals

Regulatory Requirements from FDA and USP monographs for Botanical Products

Commentary Pharmacopeial Forum 34(2) March-April 2008 Interim Revision Announcements to USP 30-NF 25 Revised June 30, 2008

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

7/16/2015. Introduction to USP. The Role of the U.S. Pharmacopeial Convention in Manufacturing OTC Medicines and Dietary Supplements.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

USP Chewable Gels Monographs

Residual Solvents: FDA/ Regulatory Perspective

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

USP <232> and <233> Understanding Your Path to Compliance with the New Elemental Impurity Chapters. Steve Wall Agilent Technologies

General concepts in the Ph. Eur.: theory and rationale

Organic Impurities in Drug Substances and Drug Products. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017

COMMENTARY TO USP31 - NF26

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

Determination of Ginseng in Dietary Supplements and Dietary Ingredients. Stakeholder Panel on Dietary Supplements (SPDS)

Topics covered by the talk

H e r b a l M e dicines' Q U A L I T Y M ANUAL. I. Introduction

USP Excipients Standards Setting Process

Expectations for Implementation in Europe

A New USP Tool The Class Monograph

Vol. 41(1) [Jan. Feb. 2015] (P) \\uspnetapp2\share\share\uspnf\printq\pager\xmlin\lyc_ _m99989.xml. Nov.

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

Understanding New USP Chapter <2232> for Trace Elemental Contaminants in Dietary Supplements and Nutraceutical Products

Revisions to USP 30 NF 25, Second Supplement

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

905 UNIFORMITY OF DOSAGE UNITS

Guidance on Limits of Foreign Matter in Herbal Ingredients

UNICEF Micronutrient Powder Specification

Change to read: BRIEFING

Safety Assessment of Botanicals and Botanical Preparations. Dr. Balasubramanian

USP and the FCC Developing Standards for Food Authenticity. Wei Zhu, Ph. D. Director, Food Chemicals U.S. Pharmacopeial Convention

Frequently Asked Questions by HPs to NCs

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA

U.S. FDA Perspective on Food Supplements/TM

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Overview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017

The USP and Compounding Nonsterile Medications

NDI: LOOKING BACK & AHEAD

Ornsurang Teerawat

USP Statement on Validation of DNA Test Methods for Regulating the Quality of Herbal Supplements

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77

COMPARISON OF QUALITY CONTROL OF TWO DIFFERENT B-COMPLEX TABLETS AND THEIR LEGISLATIVE ISSUES ON THE ALBANIAN PHARMACEUTICAL MARKET

Current FDA Perspective on Excipients NJPhAST Meeting September 15, 2016

Folic Acid in Human Nutrition

Dietary Supplement Health and Education Act of 1994 Public Law rd Congress

232 ELEMENTAL IMPURITIES LIMITS

BRIEFING Assay + + +

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

Vitamin & Supplement Guide

EPOCH ESSENTIAL OILS SCIENCE

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Pharmakon drug Poiea to make Government of each country List of Pharmacopeias: British European Indian International United state.

COMMENTARY First Supplement to USP 31-NF 26

QUALITY OF HERBAL REMEDIES

Food supplement manufacture

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Discussion at the HMPC January March Draft agreed by Quality Working Party April Adoption by CHMP for release for consultation 26 May 2005

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

syllabus (.pdf) for Prof. McCarthy s class is also available.

MONOGRAPHS (USP) Saccharin Sodium

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

16 February Cannabis Standards and their relationship to Clinical Health Outcomes

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

Method Development and Validation for Nutraceuticals

Putting the Nutritional Supplement Industry to the Test: Looking for Transparency

USP NF General Chapter <905> Uniformity of Dosage Units

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

Biowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

MULTI-COMPONENT ANALYSIS OF HEAVY METALS

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

SPS Pharma: Who we are?

REGULATORY REQUIREMENTS FOR REGISTRATION OF DIETARY SUPPLEMENTS IN ASEAN AND AFRICAN COUNTRIES

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

MEDICINES CONTROL COUNCIL

Compounding Medication Regulations

EFFECTIVE DATE: 05/02/2017

Regulatory & Quality Control Provisions for Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) Drugs

Prof. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods

SCIENTIFIC DISCUSSION

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

The Complexity of Setting Compendial Specifications for Excipient Composition and Impurities

Rock Solid Nutrition, LLC 12/22/16

AAPS Annual Meeting, San Diego, CA November 12, 2017 Short Course. Pharmaceutical Excipients: Biopharmaceutical, QC and Regulatory Considerations

Transcription:

Recent Evolution of Monographs for Dietary Supplements in USP Gabriel Giancaspro, Ph.D. Director for Dietary Supplements Documentary Standards Development USP Irvine CA, October 7, 2011

About USP

USP Founded in 1820 Founded by eleven medical visionaries in 1820 Intended to promote drug standardization and better communication between physicians and pharmacists An important milestone in American medicine and pharmacy These slides contain confidential and trade secret information, which may not be copied or disseminated without the express written permission of USP. 2002 U.S. Pharmacopeia. All rights reserved. U.S.P.C 20)03 3 Job #DSVP011SL 10/11/2011 12:21:31 PM

USP s Mission To promote the public health and benefit practitioners and patients by disseminating authoritative standard and information developed by its volunteers for medicines, other healthcare technologies, and related practices used to maintain and improve health and promote optimal healthcare delivery.

USP s Structure Not-for-profit organization 501(C)(3) Independent and non-governmental Expert knowledge base scientific activities guided by volunteer experts from different areas of healthcare Since 2010 FDA Liaisons participate in Expert Committees USP and Dietary Supplement Standards These slides contain confidential and trade secret information, which may not be copied or disseminated without the express written permission of USP. 2002 U.S. Pharmacopeia. All rights reserved. U.S.P.C 20)03 5 Job #DSVP011SL 10/11/2011 12:21:31 PM

Public Revision Process Sponsor submits Request for Revision (RR) to USP Scientific Liaison approves RR for publication in Pharmacopeial Forum Scientific Liaison requests further information or revision for the Request for Revision Public comments received on RR from Pharmacopeial Forum (90 days) Expert Committees reviews comments and accepts or rejects them, and possibly alters RR text as it deems appropriate (Not Approved) Expert Committee determines that republishing the revised RR in Pharmacopeial Forum is necessary (due to nature or significance of comments) (Approved) Request for Revision (with possible alterations) becomes effective and is published in the next USP publication. The comments and responses are posted on the USP commentary section of USP website. Comments and responses published with RR in Pharmacopeial Forum

Setting Standards for Dietary Supplements

USP Standards Official Recognition Federal Food, Drug, and Cosmetic Act Sections 201 (g) and (j), 501(b), 502(g) Official compendia standards FDA enforceable for all drugs. Conformance generally not optional. Dietary Supplement Health & Education Act (DSHEA) Section 403(s)(2)(D) of the FD&C Act A dietary supplement represented as conforming to Official Compendia specifications shall be deemed misbranded if it fails to do so. Conformance is optional.

Historical Perspective of USP Standards for Dietary Supplements 1820-1900 1942 1995 USP s standards compendium included only natural medicines. e.g. Chamomile, Valerian, and Ginger USP monographs for single ingredient vitamins. Surge of synthetic small molecule drugs, gradual omission of botanical monographs from pharmacopeias. 1820-1940 USP developed over 600 botanical monographs

Historical Perspective of USP Standards for Dietary Supplements 1995 2003 2009 In response to DSHEA, USP explored the feasibility of establishing standards and information for botanical and nonbotanical Dietary Supplements with a GMP General Chapter USP 27 NF 22 includes a dietary supplements section separated from drug standards +200 monographs for botanicals, non-botanicals, and vitamin-mineral combination products covering ~900 dietary supplement.

Continuing the Timeline USP Standards for Dietary Supplements 2009 2012 2009 NEW USP DIETARY SUPPLEMENTS COMPENDIUM All USP Dietary Supplement Monographs and relevant General Chapters plus authorized information published in a separate book. 2012 FIRST REVISION USP DIETARY SUPPLEMENTS COMPENDIUM 50 new Dietary Supplement Monographs 560 Monographs all redesigned 160 excipients used in DS 26 Safety reviews Expanded authorized information

Content for the USP Dietary Supplements Compendium General Notices and Requirements US Pharmacopeia Dietary Supplement Monographs US Pharmacopeia General Chapters Related to DS FCC Relevant Monographs FCC General Chapters Reagents and Tables Photographs and Diagrams to Aid Macroscopic and Microscopic Descriptions Reference Chromatograms (TLC and HPLC) Chemical Structures of Relevant Constituents Current Recommendations for Daily Intake from Recognized Organizations Safety Review Protocol and Safety Evaluations USPC Verification Programs for Dietary Supplements Dietary Supplements Regulatory Framework Guidance Documents

USP and Dietary Supplements Official Documentary Standards Authorized Information Compendial Reference Materials Verification Services

Communication and Education Increased education/awareness of industry about USP, to promote further implementation of standards Increased media presence e-news letters Free access to PF Compendial Updates

Old Monographs New Monographs

Ginger monograph in the 1950 s

Ginger monograph in the 1950 s

Ginger monograph in the 1950 s

Ginger USP 34

Ginger USP 34

Ginger USP 34

Ginger USP 34

Monograph Redesign Tests grouped by categories Definition Identification Assay and Strength Composition Purity (contaminants and adulterants) Specific tests Performance of Dosage Forms: Dissolution/Disintegration Headings for Tests, Procedures, and Acceptance Criteria Procedure instructions simplified and more flexible

Ginger Redesigned USP 35

Ginger Redesigned USP 35

Ginger Redesigned USP 35

Ginger Redesigned USP 35

Ginger Redesigned USP 35

Ginger Redesigned USP 35

Ginger monograph in USP Dietary Supplement Compendium

Ginger monograph in USP Dietary Supplements Compendium

What s in a USP Supplement Monograph Official and validated tests Analytical methods Criteria to define the Identity Content Quality Purity

USP Dietary Supplement Monographs Test DS Type Identity Purity/ Contaminants Quality Strength/ Composition Vitamin IR, HPLC RT, UV, Chemical Chromatographic purity, Limit Tests, Microbial, Heavy Metals Packaging, Labeling, Uniformity. Dissolution, Disintegration Spectroscopy, HPLC, Microbial Minerals Chemical Chemical Limit tests, Limit of foreign metals by AA, ICP Packaging, Labeling, Uniformity, Dissolution, Disintegration AA, ICP, Titration Non Botanicals IR, HPLC RT, UV, Chemical Chrom. purity, Limit Tests, Microbial, Heavy Metals, PCBs-Dioxins Packaging, Labeling, Uniformity, Dissolution, Disintegration Spectroscopy, HPLC, Titration Botanicals Microscopy, TLC, HPLC, GC Toxins, Aflatoxins, Heavy Metals, Pesticides, Foreign Matter, Residue On Ignition, Microbial, Negative Markers Packaging, Labeling, Extractable Matter, Uniformity, Dissolution, Disintegration HPLC, GC

Vitamin-Mineral Families Calcium with Vitamin D Tablets Calcium and Vitamin D with Minerals Capsules Minerals Capsules Minerals Tablets Oil-Soluble Vitamins Capsules Oil-Soluble Vitamins Tablets Oil- and Water-Soluble Vitamins Capsules Oil- and Water-Soluble Vitamins Oral Solution Oil- and Water-Soluble Vitamins Tablets Oil- and Water-Soluble Vitamins with Minerals Capsules Oil- and Water-Soluble Vitamins with Minerals Oral Solution Oil- and Water-Soluble Vitamins with Minerals Tablets Water-Soluble Vitamins Capsules Water-Soluble Vitamins Tablets Water-Soluble Vitamins with Minerals Capsules Water-Soluble Vitamins with Minerals Oral Solution Water-Soluble Vitamins with Minerals Tablets

Performance Standards: Disintegration and Dissolution

Setting Standards for Dietary Supplements: Problems and Solutions

Dissolution of Soft Shell Capsules Traditional Dissolution Apparatus do not work Apparatus 1: Gelatin and oil mix clogs the basket mesh Apparatus 2: Capsules usually float If rupture, low density content migrate to the surface with insufficient mixing power Need innovative testing design

Dissolution of Soft Shell Capsules Apparatus 4 Flow-through cell designed for lipid-filled soft shell capsules July-Aug. 2009 PF 35(4), USP 33 2S

Dissolution of Soft Shell Capsules Apparatus 3 DISSOLUTION CONDITIONS FOR FOLIC ACID AND INDEX VITAMINS Test 2 If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2. Medium: 45 mm citrate buffer, ph 6.0; 250 ml. Apparatus 3: 30 dpm. Screen (Top & Bottom): 56-mesh. Time: 1 hour.

Dissolution of Soft Shell Capsules Apparatus 3 Dissolution Results:

Dissolution of Soft Shell Capsules Apparatus 3 Dissolution Profiles: 120 100 % LC 80 60 40 20 Folic Acid Pyridoxine HCl 0 0 10 20 30 40 50 60 70 Time (min)

Dissolution of Soft Shell Capsules Apparatus 3 LIMITATIONS The method works for some formulations The method may need to be modified for evaluation of other soft gel capsules containing water- and oil-soluble vitamins with minerals use of surfactants use of enzymes mesh change

Dissolution of Soft Shell Capsules Apparatus 3 Formulations 2-4: All in one - soft gel capsules containing water- and oil soluble vitamins with minerals Folic Acid Release Vitamin B6 Release 120 120 100 100 % LC 80 60 40 Formulation 1 Formulation 2 Formulation 3 Formulation 4 % LC 80 60 40 Formulation 1 Formulation 2 Formulation 3 Formulation 4 20 20 0 0 10 20 30 40 50 60 70 Time (min) 0 0 10 20 30 40 50 60 70 Time (min)

Dissolution of Soft Shell Capsules Apparatus 3 Formulations 5-6 - tablet products Folic Acid Release Vitamin B6 Release 140 160 120 140 100 120 % LC 80 60 40 Formulation 1 Formulation 5 % LC 100 80 60 40 Formulation1 Formulation 5 Formulation 6 20 Formulation 6 20 0 0 10 20 30 40 50 60 70 Time (min) 0 0 10 20 30 40 50 60 70 Time (min)

Reference Standards Use Saw Palmetto: An ideal case

Alternatives to Expensive or Unavailable Marker Compounds Standardized and Quantified Extracts Surrogate compounds Problem: If the exact marker is not used, location of right compound in the chromatogram is a challenge

USP Approach to the Problem: three components linked to each other USP Monograph with a System Suitability Requirement Complex Multi-component Reference Standard Materials (Extracts) Reference Chromatogram

Use of a Reference Chromatogram in System Suitability Requirements USP characterizes reference extracts and assigns identity to relevant peaks. Each lot of reference extract is accompanied of one reference chromatogram. System suitability requirements are met if a chromatogram similar to that provided with each lot of reference standard is obtained by the analyst. The analyst now is able to identify the peaks by comparison with the reference chromatogram.

What is a similar chromatogram? Similar: permits differences in retention times but allows the identification of the relevant peaks by recognizing their relative abundance and elution order. System suitability allows modification of chromatographic system parameters (flow, column dimensions, proportions of solvents, gradient steps) in order to achieve appropriate separation.

USP Asian Ginseng Extract RS

Asian Ginseng Extract, Laboratory B

Asian Ginseng Extract, Laboratory C

Asian Ginseng two tablets,

Elemental Contaminants Traditional Pharmacopeial methods based on sulfide precipitation are: Outdated Not Specific Issues with Recoveries FDA would accept limits set by other standard setting organizations

Specifications for Elemental Contaminants Focus on Big-4 heavy metals Cd, As, Pb, and Hg (including CH 3 -Hg) 59

Approach to Dietary Supplement Limits environmen t food total exposure water drugs and DS

Limits in GC <2232> As (inorganic): 15 µg/day Cd: 5 µg/day Pb: 10 µg/day Hg (total): 15 µg/day Methylmercury: 2 µg/day (no limit in GC <232>) Speciation As Total As: 15 µg/day No need for speciation Hg Total Hg: 2 µg/day No need for speciation 2 < total Hg 15 µg/day Speciation for CH 3 -Hg

Need Speciation of Arsenic & Mercury Arsenic Highly toxic in inorganic form Nontoxic in some organic forms Mercury Highly toxic organic form Less toxic in some inorganic forms

Complementary Tests for Identification Botanicals General Chapter <563> TLC/HPTLC HPLC chromatogram description Botanical Characteristics Macroscopic Microscopic Three frequently cited examples: Ginseng, Ginkgo and Bilberry

Macroscopic Descriptions Asian Ginseng American Ginseng Notoginseng

Microscopic Descriptions

Peak ratios in fingerprint chromatograms mau 100 80 DAD1 A, Sig=203,16 Ref=360,100 (YITAO\COMPARE\RS1.D) Asian Ginseng 60 Rb1 40 Rg1 Re Rf Rc Rb2 Rd 20 0 0 10 20 30 40 50 60 70 min mau 175 150 DAD1 A, Sig=203,16 Ref=360,100 (G:\2D(1)~1.D) Notoginseng Rb 1 Rg1 Rb2 125 100 N-R1 Rd 75 50 Re 25 Rb2 0 0 10 20 30 40 50 60 70 min mau DAD1 A, Sig=203,16 Ref=360,100 (HUPING~2\XY090316.D) American Ginseng 200 Re Rb 1 150 100 50 Rg 1 Rc Rb 2 Rd 0 0 10 20 30 40 50 60 70 min

Ginkgo TLC/HPLTC

HPLC Complementary Tests Ginkgo (terpenelactones chromatogram) Ginkgo (flavonols chromatogram)

USP Bilberry Monograph, TLC test

USP Bilberry monograph, HPLC test

Thank You and Questions